NUZ-001 slowed respiratory declines in ALS patients in a Phase 1 trial, and Neurizon is working to ready it for the HEALEY ...

After her late husband's ALS diagnosis, columnist Juliet Taylor connected with other caregivers who provided support and ...

Given the variations for each person with ALS, what works for one might not be ideal for another, writes columnist.

ALS Canada has named 39 Canadians to receive the King Charles III Coronation Medal for their efforts into research and advocacy for ALS.

Certain subsets of immune NK cells were altered in the blood of people with ALS, and could serve as therapeutic targets, a ...

Scientists have developed a new method that can grow motor neurons from skin cells, which may serve as a platform for ALS ...

Neurosense reports Canadian regulators want a meeting that could lead to PrimeC's conditional approval there, and further ...

Columnist Kristin Neva writes that, with her husband's ALS, it feels like they're living in the middle of a long story with no resolution.

Guest writer Anita Newton highlights the importance of finding purpose after experiencing loss. Anita's purpose is writing ...

A cholesterol receptor protein called LDLR appears to be a key driver of neurotoxicity in sporadic ALS, per new research ...

Preclinical data with the investigational gene therapy INS1202 show improvements in survival and motor performance in ALS.